Search Results - Daniel Sutton

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    The Motion and the Noise by Matthew Daniel Sutton

    Get full text
    Article


  2. 2

    Implementation of a sensory modulation intervention in mental health outpatient services: a process evaluation study by Klara Forsberg, Daniel Sutton, Sigrid Stjernswärd, Ulrika Bejerholm, Elisabeth Argentzell

    Published in BMC Psychiatry (2025-06-01)
    Get full text
    Article


  3. 3

    Experiences of participating in a group-based sensory modulation intervention for mental health service users by Klara Forsberg, Daniel Sutton, Sigrid Stjernswärd, Ulrika Bejerholm, Elisabeth Argentzell

    Get full text
    Article


  4. 4

    Hybrid Knot and Knotless Suture Anchor Repair for Patellar Tendon Rupture by Ekene U. Ezeokoli BS, Daniel Sutton MD, Theodore B. Shybut MD

    Published in Video Journal of Sports Medicine (2022-09-01)
    Get full text
    Article


  5. 5

    877 Intermittent dosing of the ataxia telangiectasia and Rad3-related (ATR) inhibitor ceralasertib promotes antitumor immunity by remodelling the tumor immune microenvironment in p... by Matthew King, Dmitry Gabrilovich, Simon Barry, Mark Cobbold, Viia Valge-Archer, Adina Hughes, Elizabeth Hardaker, Alison Peter, Anisha Solanki, Lukasz Magiera, Gozde Kar, Stephen Fawell, Ankur Karmokar, Marta Milo, Chrysiis Michaloglou, Ricardo Miragaia, Sara Talbot, Carolyn Lam, Daniel Sutton, Scott Hoffmann, Larissa Carnevalli, Zena Wilson, Alan Lau

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  6. 6

    Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models by Lorna Hopcroft, Eleanor M. Wigmore, Stuart C. Williamson, Susana Ros, Cath Eberlein, Jennifer I. Moss, Jelena Urosevic, Larissa S. Carnevalli, Sara Talbot, Lauren Bradshaw, Catherine Blaker, Sreeharsha Gunda, Venetia Owenson, Scott Hoffmann, Daniel Sutton, Stewart Jones, Richard J. A. Goodwin, Brandon S. Willis, Claire Rooney, Elza C. de Bruin, Simon T. Barry

    Published in npj Breast Cancer (2023-08-01)
    Get full text
    Article


  7. 7

    Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models by Lorna Hopcroft, Eleanor M. Wigmore, Stuart C. Williamson, Susana Ros, Cath Eberlein, Jennifer I. Moss, Jelena Urosevic, Larissa S. Carnevalli, Sara Talbot, Lauren Bradshaw, Catherine Blaker, Sreeharsha Gunda, Venetia Owenson, Scott Hoffmann, Daniel Sutton, Stewart Jones, Richard J. A. Goodwin, Brandon S. Willis, Claire Rooney, Elza C. de Bruin, Simon T. Barry

    Published in npj Breast Cancer (2023-09-01)
    Get full text
    Article


  8. 8

    Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models by Lorna Hopcroft, Eleanor M. Wigmore, Stuart C. Williamson, Susana Ros, Cath Eberlein, Jennifer I. Moss, Jelena Urosevic, Larissa S. Carnevalli, Sara Talbot, Lauren Bradshaw, Catherine Blaker, Sreeharsha Gunda, Venetia Owenson, Scott Hoffmann, Daniel Sutton, Stewart Jones, Richard J. A. Goodwin, Brandon S. Willis, Claire Rooney, Elza DeBruin, Simon T. Barry

    Published in npj Breast Cancer (2023-08-01)
    Get full text
    Article


  9. 9

    A comprehensive welfare scoring system for graft versus host disease clinical assessment in humanised mouse models used for pharmaceutical research by Alice Nowak, Rebecca Marlow, Kelli Ryan, Jean-Martin Lapointe, Daniel Sutton, Alan Sharpe, Lucy Crook, Jennifer A. Walker, Emma Little, John Peverill, Adam Holberry-Brown, Emma Wassell, Robbie McLaren-Jones, Chelsea Cavanagh, Alex Vlad Dobre, Tamara Baker, Matthew Clayton, Natasha A. Karp, Michiel Plugge, Aurélie A. Thomas, Simon J. Dovedi, Suzanne I. Sitnikova, Natalie Burrows

    Published in Frontiers in Immunology (2025-06-01)
    Get full text
    Article


  10. 10

    The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment by Elizabeth L. Hardaker, Emilio Sanseviero, Ankur Karmokar, Devon Taylor, Marta Milo, Chrysis Michaloglou, Adina Hughes, Mimi Mai, Matthew King, Anisha Solanki, Lukasz Magiera, Ricardo Miragaia, Gozde Kar, Nathan Standifer, Michael Surace, Shaan Gill, Alison Peter, Sara Talbot, Sehmus Tohumeken, Henderson Fryer, Ali Mostafa, Kathy Mulgrew, Carolyn Lam, Scott Hoffmann, Daniel Sutton, Larissa Carnevalli, Fernando J. Calero-Nieto, Gemma N. Jones, Andrew J. Pierce, Zena Wilson, David Campbell, Lynet Nyoni, Carla P. Martins, Tamara Baker, Gilberto Serrano de Almeida, Zainab Ramlaoui, Abdel Bidar, Benjamin Phillips, Joseph Boland, Sonia Iyer, J. Carl Barrett, Arsene-Bienvenu Loembé, Serge Y. Fuchs, Umamaheswar Duvvuri, Pei-Jen Lou, Melonie A. Nance, Carlos Alberto Gomez Roca, Elaine Cadogan, Susan E. Critichlow, Steven Fawell, Mark Cobbold, Emma Dean, Viia Valge-Archer, Alan Lau, Dmitry I. Gabrilovich, Simon T. Barry

    Published in Nature Communications (2024-02-01)
    Get full text
    Article


Search Tools: